|
|
Efficacy comparison of two vascular reconstructions on the treatment for adult Moyamoya disease |
LI Hongkai XU Haitao YANG Sheng ZHANG Xiangyang HUANG Shulan▲ |
Department of Neurosurgery, Renmin Hospital of Wuhan University, Hubei Province, Wuhan 430060, China |
|
|
Abstract Objective To compare the efficacy of Superficial temporal artery-middle cerebral artery anastomosis combining with original encephaloduromyosynangiosis (STA-MCA+EDMS) and encephalo-duro-arterio-myo-synangiosis (EDAMS) on the treatment for adult Moyamoya disease. Methods Seventy-three clinical cases of adult Moyamoya disease treated with vascular reconstruction in Wuhan People Hospital from April 2013 to April 2017 were enrolled for retrospective analysis. On the basis of different treatments, they were divided into two groups, STA-MCA+EDMS group with 35 cases and EMDS group with 38 cases. Digital subtraction angiography (DSA) results, computed tomography perfusion (CTP) results, modified Rankin scale (mRS) scores and treatment effecacy were compared between the two groups. Postoperative complications and follow-up results were recorded and compared. Results Revascularization was better in STA-MCA+EDMS group than the EMDS group, the difference was significant (P < 0.05). Cerebral blood flow (CBF) value in the STA-MCA+EDMS group: 2 weeks post-operation was higher than that of 3 months post-operation; 3 months post-operation was higher than that before operation; 3 months post-operation was higher than that of 2 weeks post-operation; all the differences were statistically significant (P < 0.05). The mRS scores in the STA-MCA+EDMS group: the scores before operation was higher than that of 3 months post-operation; 2 weeks post-operation scores higher than that of 3 months post-operation; the scores before operation was higher than that of 2 weeks post-operation; all the differences were statistically significant (P < 0.05). The mRS scores in the EDAMS group: the scores before operation was higher than that of 3 months post-operation; 2 weeks post-operation scores higher than that of 3 months post-operation; the differences were significant (P < 0.05). The scores before operation was higher than that of 2 weeks post-operation, and the difference had no significance (P > 0.05). The mRS scores of 2 weeks post-operation in the STA-MCA+EDMS group was lower than that of EDAMS group, and the difference had no significance (P > 0.05). The mRS scores of 3 month post-operation in the STA-MCA+EDMS group was lower than that of EDAMS group, and the difference was significant (P < 0.05). Perioperative complication rate in the EDAMS group was lower than the STA-MCA+EDMS group; postoperative recurrent rate in the STA-MCA+EDMS group was lower than the EDAMS group; and the differences had no significance (P > 0.05). Conclusion Compared to EDAMS, STA-MCA+EDMS has prominent efficacy in short period post operation. STA-MCA+EDMS builds collateral circulation better and improves patients’ neural symptoms. Perioperative complication rate and postoperative recurrent rate in the two groups have no differences. The long-term efficacy is expected to be observed.
|
|
|
|
|
[1] Hishikawa T,Sugiu K,Date I,et al. Moyamoya Disease:A Review of Clinical Research [J]. Acta Med Okayama,2016, 70(4):229-236.
[2] 任斌,段炼.2012年烟雾病(Willis环自发性闭塞)诊断治疗指南(日本)的解读[J].中国脑血管病杂志,2014,11(1):6-9.
[3] Ogawa S,Abe H,Katsuta T,et al. Early and noninvasive evaluation using superficial temporal artery duplex ultrasonography after indirect bypass for adult ischemic moyamoya disease [J]. Acta Neurochir(Wien),2017,159(3):577-582.
[4] Thines L,Petyt G,Aguettaz P,et al. Surgical management of Moyamoya disease and syndrome:Current concepts and personal experience [J]. Rev Neurol(Paris),2015,171(1):31-44.
[5] Li Y,Cikla U,Baggott C,et al. Surgical treatment of adult moyamoya disease with combined STA-MCA bypass and EDAS:demonstration of technique in video presentation [J]. Turk Neurosurg,2015,25(1):126-131.
[6] 施红芳,缪小惠,李子文,等.4D CTA与DSA在烟雾病分级中的对比研究[J].影像诊断与介入放射学,2017,26(6):476-480.
[7] 左智炜.烟雾病患者皮层厚度及血流动力学反应研究[D].北京:中国人民解放军军事医学科学院,2015.
[8] 刘兴利,薛静,高培毅,等.探讨不同输入动脉对烟雾病CT灌注参数的影响[J].放射学实践,2016,31(2):151-154.
[9] 杨升,黄书岚.CTP在STA-MCA治疗烟雾病中的应用[J].医学研究杂志,2017,46(7):148-152.
[10] 马菲韩,胡娜,陈劲草,等.经颅多普勒联合mRS评分在颅内外血管重建术治疗烟雾病疗效评价中的应用[J].临床外科杂志,2015,23(9):705-707.
[11] Arias EJ,Dunn GP,Washington CW,et al. Surgical revascularization in North American adults with moyamoya phenomenon:Long-Term angiographic follow-up[J]. J Stroke,2015,24(7):1597-1608.
[12] 周锡炜,王建祯,秦至臻.烟雾病手术时机与术后并发症分析[J].中国实用神经疾病杂志,2017,20(5):50-52.
[13] Bao XY,Duan L,Yang WZ,et al. Clinical features,surgical treatment,and long-term outcome in pediatric patients with moyamoya disease in China [J]. Cerebrovasc Dis,2012,34(4):305-313.
[14] 刘兴炬,张东,王硕,等.手术与保守治疗烟雾病患者的单中心长期随访观察[J].中华医学杂志,2012,92(9):604-607.
[15] See AP,Ropper AE,Underberg DL,et al. Down syndrome and moyamoya:clinical presentation and surgical management [J]. J Neurosurg Pediatr,2015,16(1):58-63.
[16] Arias EJ,Derdeyn CP,Jr DR,et al. Advances and surgical considerations in the treatment of moyamoya disease [J]. Neurosurgery,2014,74 Suppl 1:S116-S125.
[17] Wan M,Duan L. Recent progress in hemorrhagic moyamoya disease [J]. Br J Neurosurg,2015,29(2):189-191.
[18] Qian C,Yu X,Li J,et al. The Efficacy of Surgical Treatment for the Secondary Prevention of Stroke in Symptomatic Moyamoya Disease:A Meta-Analysis [J]. Medicine(Baltimore),2015,94(49):e2218.
[19] 高登科,姚一,江建东,等.出血型烟雾病的临床特征及手术疗效[J].中华神经外科杂志,2017,33(1):36-40.
[20] 周锡炜,王建祯,马妍.国内烟雾病的文献评价与现状[J].中国实用神经疾病杂志,2017,20(10):1-4.
[21] See AP,Ropper AE,Underberg DL,et al. Down syndrome and moyamoya:clinical presentation and surgical management [J]. J Neurosurg Pediatr,2015,16(1):58-63.
[22] 王泳,李海东,刘洁,等.高压氧在成人烟雾病治疗中的应用[J].首都医科大学学报,2017,38(5):750-752. |
|
|
|